Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Norgine logo

Norgine opens new £4.5 million warehouse

November 17, 2015 Manufacturing and Production, Research and Development Norgine, Temperature control, Wales, manufacturing, production, temperature-control

Norgine has opened a new £4.5 million temperature controlled warehouse on its current site in Hengoed, Wales.  The Dutch-based firm …
News
dr_kevin_johnson_-_chairman

Crescendo Biologics appoints Dr Kevin Johnson as chairman

November 17, 2015 Research and Development

Crescendo Biologics, the drug discovery and developer of Humabody VH therapeutics, has announced the appointment of Dr Kevin Johnson as non-executive …
Appointment
abbvie_0

AbbVie rules out joining the biosimilars bandwagon

November 17, 2015 Manufacturing and Production, Research and Development

AbbVie says it has ruled out moving into the biosimilars market to stave off competition once its blockbuster drug Humira …
News
genmab

FDA approves ‘first of its kind’ blood cancer drug

November 17, 2015 Manufacturing and Production, Research and Development

The FDA has approved Genmab’s drug Darzalex for patients with multiple myeloma. Darzalex (daratumumab) is the first human CD38 monoclonal antibody …
News
Diabetes treatments

Featured Market Report: Type 2 Diabetes – Epidemiology Forecast to 2024

November 16, 2015 Manufacturing and Production, Research and Development diabetes, market reports

Diabetes is one of the most common non-communicable diseases worldwide and is an escalating public health problem globally, with an …
Feature
baxalta_logo

FDA approves Baxalta Haemophilia A treatment

November 16, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

The US FDA has approved Baxalta’s twice-weekly therapy Adynovate for use in adults and adolescents, aged 12 years plus, with …
News
diabetes_insulin_syringes

Novo Nordisk invests $20m in diabetes research following study

November 16, 2015 Research and Development, Sales and Marketing

Novo Nordisk has unveiled plans to combat urban diabetes in a $20 million investment offering expert resources and research funds …
News
amgen_flag

Amgen’s Humira biosimilar succeeds in Phase III arthritis study

November 16, 2015 Research and Development, Sales and Marketing Amgen, Humira

Amgen says its Humira (adalimumab) biosimilar candidate ABP 501 proved its clinical equivalence to Abbvie’s blockbuster drug in a head-to-head …
News
mene_pangalos

New appointments for AstraZeneca’s Mene Pangalos

November 13, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Mene Pangalos, executive vice president of the IMED Biotech Unit at AstraZeneca UK, has accepted two prestigious appointments that …
Appointment
google logo

Google and AHA to fund $50m cardiovascular disease project

November 13, 2015 Medical Communications, Research and Development American Heart Association, cardiovascular disease, google, heart disease

The American Heart Association and Google Life Sciences have announced a joint research collaboration to bring ‘unconventional thinking’ to the …
News
BI building

Boehringer cuts R&D budget to €11bn to focus on collaborations

November 13, 2015 Medical Communications, Research and Development Boehringer Ingelheim

Boehringer Ingelheim has launched its new research and development strategy, committing €11 billion to R&D over the next five years. …
News
Proteus Digital and Otuska's 'digital pill'

The ‘Pharmasaurus’ aims to evolve into a leader in the digital age

November 12, 2015 Medical Communications, Research and Development Bayer, Roche, digital health, pharma

Pharma’s new-found willingness to embrace all aspects of the digital age, and use it both to its advantage and that …
Feature
Benlysta

GSK ready for lupus drug push

November 12, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, GSK, Lupus, SLE, belimumab, systemic lupus erythematosus

Having presented positive late-stage results for a new formulation of its inflammatory drug Benlysta, GSK says it will file supplementary …
News

Astellas to acquire Ocata Therapeutics in $379m buyout

November 11, 2015 Research and Development, Sales and Marketing Astellas, Ocata, Stem cells, cell therapy, ophthalmology

Astellas Pharma has agreed to buy Ocata, a firm specialising in cloning and embryonic stem cell therapies, for $379 million. …
News
roche

FDA approves Roche skin cancer combination

November 11, 2015 Research and Development, Sales and Marketing Cotellic, FDA, Genentech, Roche, Zelboraf, cobimetinib, melanoma, skin cancer, vemurafenib

The FDA has approved the skin cancer drug Cotellic for certain forms of melanoma in combination with another Roche cancer …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025